文献速递临床试验与 GCP

预后良好女性体外受精中囊胚期与卵裂期胚胎移植策略的累积活产率:多中心随机对照试验

Cumulative live birth rate of a blastocyst versus cleavage stage embryo transfer policy during in vitro fertilisation in women with a good prognosis: multicentre randomised controlled trial.
PubMed 文献 · BMJ · 2024-09-16

这项在荷兰21家医院和诊所开展的多中心随机对照试验纳入1202名取卵后第2天至少有4枚胚胎的预后良好女性,比较囊胚期与卵裂期胚胎移植策略。结果显示两组累积活产率无显著差异(58.9% vs 58.4%;RR 1.01,95%CI 0.84-1.22),囊胚组新鲜胚胎移植后活产率较高、累积妊娠丢失率较低、达到活产所需平均移植次数较少,但单胎中度早产发生率较高。

要点

  • 囊胚期与卵裂期移植累积活产率无显著差异(58.9% vs 58.4%;RR 1.01,95%CI 0.84-1.22)。
  • 囊胚组新鲜胚胎移植后活产率较高(RR 1.26,95%CI 1.00-1.58)。
  • 囊胚组单胎中度早产(32至<37周)发生率较高(RR 1.87,95%CI 1.05-3.34)。

核心结论

  • 在体外受精治疗中至少有4枚胚胎可利用的女性中,囊胚期胚胎移植的累积活产率与卵裂期胚胎移植相似。

研究设计与样本

  • 多中心随机对照试验,在荷兰21家医院和诊所开展,时间为2018年8月18日至2021年12月17日。
  • 共纳入1202名取卵后第2天至少有4枚胚胎可利用的女性,随机分为囊胚期胚胎移植组(n=603)和卵裂期胚胎移植组(n=599)。
  • 囊胚组和卵裂组分别在取卵后第5天和第3天进行胚胎移植,剩余胚胎行冷冻保存;按意向性分析,并进行符合方案方案的二次分析。

主要发现

  • 囊胚组与卵裂组的累积活产率无显著差异:58.9%(355/603)vs 58.4%(350/599),风险比1.01,95%CI 0.84-1.22。
  • 囊胚组新鲜胚胎移植后活产率较高:风险比1.26,95%CI 1.00-1.58。
  • 囊胚组累积妊娠丢失率较低:风险比0.68,95%CI 0.51-0.89。
  • 囊胚组达到活产所需平均胚胎移植次数较少:1.55 vs 1.82,P<0.001。
  • 囊胚组单胎中度早产(32至<37周)发生率较高:风险比1.87,95%CI 1.05-3.34。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate whether embryo transfers at blastocyst stage improve the cumulative live birth rate after oocyte retrieval, including both fresh and frozen-thawed transfers, and whether the risk of obstetric and perinatal complications is increased compared with cleavage stage embryo transfers during in vitro fertilisation (IVF) treatment. DESIGN: Multicentre randomised controlled trial. SETTING: 21 hospitals and clinics in the Netherlands, 18 August 2018 to 17 December 2021. PARTICIPANTS: 1202 women with at least four embryos available on day 2 after oocyte retrieval were randomly assigned to either blastocyst stage embryo transfer (n=603) or cleavage stage embryo transfer (n=599). INTERVENTIONS: In the blastocyst group and cleavage group, embryo transfers were performed on day 5 and day 3, respectively, after oocyte retrieval, followed by cryopreservation of surplus embryos. Analysis was on an intention-to-treat basis, with secondary analyses as per protocol. MAIN OUTCOME MEASURES: The primary outcome was the cumulative live birth rate per oocyte retrieval, including results of all frozen-thawed embryo transfers within a year after randomisation. Secondary outcomes included cumulative rates of pregnancy, pregnancy loss, and live birth after fresh embryo transfer, number of embryo transfers needed, number of frozen embryos, and obstetric and perinatal outcomes. RESULTS: The cumulative live birth rate did not differ between the blastocyst group and cleavage group (58.9% (355 of 603) v 58.4% (350 of 599; risk ratio 1.01, 95% confidence interval (CI) 0.84 to 1.22). The blastocyst group showed a higher live birth rate after fresh embryo transfer (1.26, 1.00 to 1.58), lower cumulative pregnancy loss rate (0.68, 0.51 to 0.89), and lower mean number of embryo transfers needed to result in a live birth (1.55 v 1.82; P<0.001). The incidence of moderate preterm birth (32 to <37 weeks) in singletons was higher in the blastocyst group (1.87, 1.05 to 3.34). CONCLUSION: Blastocyst stage embryo transfers resulted in a similar cumulative live birth rate to cleavage stage embryo transfers in women with at least four embryos available during IVF treatment. TRIAL REGISTRATION: International Clinical Trial Registry Platform NTR7034.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Cornelisse S, Fleischer K, van der Westerlaken L, et al. Cumulative live birth rate of a blastocyst versus cleavage stage embryo transfer policy during in vitro fertilisation in women with a good prognosis: multicentre randomised controlled trial. BMJ. 2024. PMID: 39284610. doi:10.1136/bmj-2024-080133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。